Get the Stockscreener App
1.60
2.44%
-0.04
After Hours:
1.62
0.02
+1.25%
Medicinova Inc Stock (MNOV) Forecast
The Medicinova Inc (MNOV) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $6.1829, representing a +286.43% increase from the current price of $1.60. The highest analyst price target is $6.3346, and the lowest is $6.0312.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month MNOV Price Target
Average 4.3312
(+170.70% Upside)
Is Medicinova Inc (MNOV) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 31.93 | Neutral |
| STOCH(9,6) | 4.2491 | Buy |
| STOCHRSI(14) | 9.7587 | Buy |
| MACD(12,26) | -0.0813 | Sell |
| ADX(14) | 25.11 | Sell |
| William %R | -100.00 | Buy |
| CCI(14) | -125.44 | Sell |
Buy: 3
Sell: 3
Neutral: 1
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
1.7575
Sell
|
1.7279
Sell
|
| MA20 |
1.8267
Sell
|
1.7995
Sell
|
| MA50 |
1.9387
Sell
|
1.8847
Sell
|
| MA100 |
1.9282
Sell
|
1.8715
Sell
|
| MA200 |
1.6983
Sell
|
1.7862
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, MNOV could be considered a Strong Sell, with 17 technical analysis indicators signaling 3 Buy signals, 13 signaling Sell signals and 1 Neutral signals. This might not be a good time to consider opening new positions on MNOV, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 31.93 indicates that MNOV is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 4.2491 indicates that MNOV is oversold. This indicates that MNOV price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 9.7587 indicates that MNOV is oversold. This suggests that MNOV price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 25.11 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -125.44 indicates that MNOV is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.
Long-term MNOV price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Medicinova Inc financial reports and earnings history, Medicinova Inc (MNOV) stock could reach $13.16 by 2030, $8.1966 by 2040 and $26.56 by 2050. See the projected annual prices until 2050 of the Medicinova Inc stock below:
- Medicinova Inc (MNOV) is expected to reach an average price of $2.4602 in 2035, with a high prediction of $2.5943 and a low estimate of $2.5502. This indicates an $53.76% rise from the last recorded price of $1.60.
- Medicinova Inc (MNOV) stock is projected to chart a bullish course in 2040, with an average price target of $7.977, representing an $398.56% surge from its current level. The forecast ranges from a conservative $7.987 to a sky-high $8.1966.
- Our analysts predict Medicinova Inc (MNOV) to jump 901.02% by 2045, soaring from $16.05 to an average price of $16.02, potentially reaching $16.27. While $16.05 is the low estimate, the potential upside is significant.
- Medicinova Inc (MNOV) stock is expected to climb by 2050, reaching an average of $25.96, a $1,522% jump from its current level. However, a wide range of estimates exists, with high and low targets of $26.56 and $26.36, respectively, highlighting the market's uncertainty.
Medicinova Inc Stock (MNOV) Year by Year Forecast
Medicinova Inc Stock (MNOV) Price Forecast for 2025
Medicinova Inc Stock (MNOV) is expected to reach an average price of $4.6118 in 2025, with a high prediction of $6.3346 and a low estimate of $2.889. This indicates an +188.24% rise from the last recorded price of $1.60.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| April, 2025 | $6.1091 | $6.0312 | $6.3346 | +281.82% |
| May, 2025 | $4.4171 | $4.3626 | $6.0536 | +176.07% |
| June, 2025 | $3.9651 | $4.1951 | $4.1261 | +147.82% |
| July, 2025 | $3.9275 | $3.9875 | $3.7986 | +145.47% |
| August, 2025 | $3.5855 | $3.7855 | $3.6165 | +124.09% |
| September, 2025 | $2.7235 | $2.889 | $4.171 | +70.22% |
| October, 2025 | $3.8159 | $3.348 | $3.5615 | +138.50% |
| November, 2025 | $3.4839 | $3.1749 | $3.4639 | +117.75% |
| December, 2025 | $2.9564 | $3.2163 | $3.3184 | +84.77% |
Medicinova Inc Stock (MNOV) Price Forecast for 2026
The predicted value for Medicinova Inc (MNOV) in 2026 is set at an average of $2.5812. Estimates vary from a peak of $3.2841 to a trough of $1.8783, indicating an +61.32% surge from the present price of $1.60.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $2.4344 | $2.7244 | $2.5309 | +52.15% |
| February, 2026 | $2.2923 | $2.3278 | $2.3888 | +43.27% |
| March, 2026 | $2.4503 | $2.5903 | $2.9113 | +53.14% |
| April, 2026 | $2.0928 | $1.8783 | $1.9548 | +30.80% |
| May, 2026 | $1.9907 | $2.2607 | $2.9738 | +24.42% |
| June, 2026 | $2.9187 | $2.6742 | $2.6597 | +82.42% |
| July, 2026 | $3.3212 | $3.1922 | $3.2712 | +107.57% |
| August, 2026 | $3.0591 | $3.2391 | $3.1857 | +91.20% |
| September, 2026 | $3.3116 | $3.1078 | $2.9736 | +106.98% |
| October, 2026 | $3.3396 | $3.4406 | $3.2396 | +108.72% |
| November, 2026 | $2.9675 | $3.0675 | $3.2841 | +85.47% |
| December, 2026 | $2.92 | $2.8587 | $2.7455 | +82.50% |
Medicinova Inc Stock (MNOV) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Medicinova Inc (MNOV) is $3.0495, with a high forecast of $3.5654 and a low forecast of $2.5336. This indicates an +90.59% increase from the last price of $1.60.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $2.908 | $2.8845 | $2.799 | +81.75% |
| February, 2027 | $3.206 | $2.9915 | $2.887 | +100.37% |
| March, 2027 | $3.3884 | $3.1821 | $3.0184 | +111.78% |
| April, 2027 | $3.5764 | $3.5129 | $3.4664 | +123.52% |
| May, 2027 | $3.5844 | $3.6244 | $3.5654 | +124.02% |
| June, 2027 | $3.3768 | $3.4523 | $3.3845 | +111.05% |
| July, 2027 | $2.9648 | $3.1348 | $3.3413 | +85.30% |
| August, 2027 | $2.5628 | $2.5728 | $2.9393 | +60.17% |
| September, 2027 | $2.8252 | $2.8673 | $2.8607 | +76.58% |
| October, 2027 | $2.6232 | $2.7432 | $2.8042 | +63.95% |
| November, 2027 | $2.4412 | $2.5967 | $2.5027 | +52.57% |
| December, 2027 | $2.3636 | $2.5336 | $2.5191 | +47.73% |
Medicinova Inc Stock (MNOV) Price Forecast for 2028
In 2028, Medicinova Inc (MNOV) is projected to reach an average price of $1.6272, with a high projection of $2.5116 and a low estimate of $0.7428. This indicates an +1.70% rise from the last price of $1.60.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $2.6116 | $2.5481 | $2.5116 | +63.23% |
| February, 2028 | $2.3996 | $2.4496 | $2.4261 | +49.97% |
| March, 2028 | $2.352 | $2.352 | $2.3831 | +47.00% |
| April, 2028 | $1.96 | $2.15 | $2.1665 | +22.50% |
| May, 2028 | $2.0725 | $1.619 | $1.6925 | +29.53% |
| June, 2028 | $1.5405 | $1.566 | $1.837 | -3.72% |
| July, 2028 | $1.4084 | $1.4239 | $1.3794 | -11.97% |
| August, 2028 | $1.3709 | $1.4459 | $1.4319 | -14.32% |
| September, 2028 | $1.2689 | $1.3689 | $1.3554 | -20.70% |
| October, 2028 | $1.1668 | $1.2368 | $1.1223 | -27.07% |
| November, 2028 | $0.9593 | $1.0393 | $1.0208 | -40.04% |
| December, 2028 | $0.7073 | $0.7428 | $0.8738 | -55.80% |
Medicinova Inc Stock (MNOV) Price Forecast for 2029
The 2029 price forecast for Medicinova Inc Stock (MNOV) is $5.1388 on average, with a high prediction of $10.25 and a low estimate of $0.0326. This represents an +221.17% increase from the previous price of $1.60.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.4497 | $0.4863 | $0.5118 | -71.89% |
| February, 2029 | $0.4177 | $0.3987 | $0.2677 | -73.89% |
| March, 2029 | $0.5057 | $0.2367 | $0.2429 | -68.40% |
| April, 2029 | $0.4036 | $0.4736 | $0.3592 | -74.77% |
| May, 2029 | $0.4461 | $0.3871 | $0.3326 | -72.12% |
| June, 2029 | $0.3041 | $0.3341 | $0.3506 | -80.99% |
| July, 2029 | $0.4421 | $0.3686 | $0.4121 | -72.37% |
| August, 2029 | $0.3545 | $0.355 | $0.3045 | -77.84% |
| September, 2029 | $0.3425 | $0.3335 | $0.2535 | -78.59% |
| October, 2029 | $0.055 | $0.135 | $0.2078 | -96.57% |
| November, 2029 | $0.0871 | $0.0461 | $0.3015 | -94.56% |
| December, 2029 | $10.31 | $0.0326 | $10.25 | +544.38% |
Medicinova Inc Stock (MNOV) Price Forecast for 2030
Medicinova Inc Stock (MNOV) is expected to reach an average price of $13.39 in 2030, with a high forecast of $16.16 and a low forecast of $10.63. This signifies an +737.13% surge from the last price of $1.60.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $13.51 | $10.63 | $13.16 | +744.68% |
| February, 2030 | $12.10 | $13.20 | $12.96 | +656.30% |
| March, 2030 | $13.09 | $13.06 | $12.64 | +717.93% |
| April, 2030 | $13.40 | $13.68 | $13.49 | +737.67% |
| May, 2030 | $13.65 | $13.12 | $13.85 | +753.29% |
| June, 2030 | $13.69 | $13.97 | $13.92 | +755.85% |
| July, 2030 | $13.62 | $13.17 | $13.21 | +751.16% |
| August, 2030 | $13.49 | $13.30 | $13.54 | +743.41% |
| September, 2030 | $13.58 | $13.80 | $13.75 | +748.78% |
| October, 2030 | $13.93 | $13.61 | $14.11 | +770.34% |
| November, 2030 | $15.97 | $15.05 | $15.77 | +898.21% |
| December, 2030 | $16.48 | $16.22 | $16.16 | +929.83% |
6.45%
1.23%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):